Life sciences lawyers lawyers | Trowers & Hamlins law firm -Trowers & Hamlins

Our life sciences team comprises experts from across the firm who work collaboratively to provide sector leading advice to our life science and healthcare clients.

The life sciences sector stands out as a growth area in the UK and this coupled with a Government focus on life sciences and the opportunities fuelled by the increasing usage of innovative technology in life sciences has seen the sector attracting increasing investment. This is fuelling demand for space, and as a result the life science sector has become a hot ticket for real estate, investment and innovation.

We are one of very few firms capable of moving across all of these boundaries and, therefore, capable not just of moving with the market but working with it as it evolves. We understand all aspects of the sector, working with investors, local authorities, developers and operators. Demonstrating excellence within life sciences and healthcare requires the ability to work across many facets, especially when they are coalescing more and more as a consequence of Government policy.

Our life sciences team comprises experts from across the firm who work collaboratively to provide sector leading advice to our life science and healthcare clients. We have long-standing expertise in advising companies and investors in the pharmaceutical, medical research, health-tech, fertility and private healthcare sectors. Our clients range from tech start-ups to very large companies and investment funds, and we work closely with our international offices and our network of firms worldwide to provide global solutions.

Our expert group works closely with our clients to advise them throughout their lifecycle, providing specialist advice in relation to regulatory, procurement, public and private funding, corporate, commercial, data privacy, IP, dispute resolution, construction and real estate matters.

Why choose our life science lawyers?

We are renowned for our in-depth industry knowledge and have advised on a large number of prestigious and very high value life sciences projects. For example we are currently advising the Ellison Institute of Technology on its development of a ground-breaking cancer treatment and research facility at Oxford Science Park with a projected GDV of over £1.5 billion.

Strong cross sector experience offering a full-service offering
In depth understanding of the life science ecosystem and developing market
Track record working with investors, operators, tec pharmaceutical companies and local authorities

Tom Calnan

Partner

London

+44 (0)20 7423 8685 Email me

Paul Bartter

Partner

London

+44 (0)20 7423 8115 Email me

Our areas of focus:

Science parks and superclusters

We support clients through all phases of major development projects across the Golden Triangle and emerging superclusters, leading the way in the collaborative integration of construction project teams for the delivery of major UK and European projects. Our expertise spans land acquisition, procurement, planning, environmental, construction, leasing, commissioning and operational stages. Recent examples of work include advising the Ellison Institute of Technology at Oxford Science Park, as above.

Research and development

We are sector leading in our work repurposing existing buildings for R&D / laboratory / clinical usage. Our experience includes the creation of a proton beam therapy centre, and advising Kadans Science Partner, acting through their development manager, Mission Street, on the construction procurement and financing for the refurbishment of a combination of laboratory space, offices, and collaboration space.

Fertility

Our fertility group advises fertility clinics and sperm banks on regulatory compliance, sector-specific contracts, data privacy, and mergers and acquisitions. Recent examples of work include acting upon the sale of fertility clinics including advice upon regulatory issues, and drafting complex agreements to import gametes from other jurisdictions.

Pharmaceutical and biotechnology

We advise investors into the pharma sector, pharma companies and other key sector operators upon financing and mergers and acquisitions, collaboration, innovation, data privacy and cybersecurity, procurement and contracts. Examples of work include acting in a multimillion pound investment into an international pharma company and its existing portfolio of commercialised products, and drafting and negotiating a large number of R&D and development agreements for a client covering pre-clinical to manufacture phases.

Innovation

We act for a large number of health-tech companies and have particular expertise in advising upon technology and AI contracts in the fertility sector. Examples of work include advising an international private cancer clinic upon the procurement of key patient software and advising a consortium of European companies upon the anonymisation of patient data from a number of fertility clinics to create a database to be used to train AI algorithms to improve patient outcomes.